International Clinical Trial: Phase 1 Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07453784) titled 'Phase 1 Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Abivax S.A.

Condition: Healthy

Intervention: Drug: Obefazimod 50 mg Capsule

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 2026

Target Sample Size: 44

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/study/NCT07453784

P...